Related Experiment Video

Updated: Jun 12, 2026

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model
04:39

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model

Published on: March 17, 2023

[Mevastatin inhibits the differentiation of thyroid-associated ophthalmopathy derived orbital preadipocytes]

Wenshu Yi1, Xueliang Xu

  • 1Department of Ophthalmology, Xiangya Hospital, Central South University, Changsha 410008, China.

Zhong Nan Da Xue Xue Bao. Yi Xue Ban = Journal of Central South University. Medical Sciences
|June 15, 2010
PubMed
Abstract

Insights

Mevastatin inhibits thyroid-associated ophthalmopathy (TAO) orbital preadipocyte differentiation by reducing PPAR-gamma mRNA expression. This inhibition is concentration-dependent and more potent when applied earlier in the differentiation process.

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Cell Biology

Context:

  • Thyroid-associated ophthalmopathy (TAO) involves orbital adipose tissue remodeling.
  • Orbital preadipocytes play a crucial role in adipose tissue expansion in TAO.
  • Understanding factors influencing orbital preadipocyte differentiation is vital for TAO pathogenesis.

Purpose:

  • To investigate the effect of mevastatin on peroxisome-proliferator-activated receptor-gamma (PPAR-gamma) mRNA expression.
  • To determine mevastatin's impact on the differentiation of TAO-derived orbital preadipocytes in vitro.
  • To assess the concentration- and stage-dependent effects of mevastatin on adipogenesis.

Summary:

  • Mevastatin treatment led to decreased PPAR-gamma mRNA expression and reduced intracellular fat accumulation in TAO orbital preadipocytes.
  • The inhibitory effect of mevastatin on differentiation was concentration-dependent.
  • Earlier application of mevastatin during the differentiation process resulted in stronger inhibition.

Impact:

  • Mevastatin demonstrates potential as an inhibitor of orbital adipogenesis in TAO.
  • The findings suggest a mechanism involving PPAR-gamma downregulation.
  • This research may inform therapeutic strategies targeting orbital fat accumulation in TAO.

Related Concept Videos

Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Functions of Thyroid Hormones01:18

Functions of Thyroid Hormones

The thyroid hormone (TH) plays a pivotal role in the intricate orchestration of physiological processes, exerting profound effects on development, metabolism, and homeostasis throughout different life stages.
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...